Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |